Table 1.
Characteristics of the frequency of the studied subgroups, taking into account the sex and age of the patients.
| Female | Male | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Age (Years) | |||||||||||
| SARS-CoV-2 and Vaccination Status | N | ≤35 | 36–45 | 46–55 | 56–65 | 65+ | ≤35 | 36–45 | 46–55 | 56–65 | 65+ |
| Unvaccinated | |||||||||||
| Without prior SARS-CoV-2 infection | 24 | 4 | 2 | 3 | 5 | 0 | 2 | 4 | 2 | 1 | 1 |
| Convalescents | 97 | 13 | 14 | 14 | 16 | 7 | 4 | 7 | 8 | 7 | 7 |
| Vaccinated with the first dose (2–3 weeks after vaccination) | |||||||||||
| Without prior SARS-CoV-2 infection | 19 | 6 | 2 | 1 | 2 | 2 | 0 | 2 | 0 | 2 | 2 |
| Convalescents | 9 | 1 | 1 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 1 |
| Vaccinated with the second dose (1–5 weeks after vaccination) | |||||||||||
| Without prior SARS-CoV-2 infection | 203 | 32 | 38 | 40 | 36 | 13 | 5 | 12 | 9 | 11 | 7 |
| Convalescents | 125 | 14 | 35 | 23 | 24 | 8 | 6 | 4 | 3 | 3 | 5 |
| Total | 477 | 70 | 92 | 84 | 86 | 30 | 17 | 29 | 22 | 24 | 23 |